Detalles de la búsqueda
1.
Efficacy of MEK inhibition in patients with histiocytic neoplasms.
Nature;
567(7749): 521-524, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867592
2.
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
Cancer;
130(4): 576-587, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37886874
3.
Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.
Adv Anat Pathol;
31(1): 1-14, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638549
4.
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes.
Gynecol Oncol;
182: 32-38, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246044
5.
A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
Gynecol Oncol;
182: 75-81, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262242
6.
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Gynecol Oncol;
186: 104-109, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640773
7.
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Gynecol Oncol;
180: 35-43, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041901
8.
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Gynecol Oncol;
2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493020
9.
Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma.
Int J Gynecol Pathol;
43(3): 203-214, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085957
10.
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Int J Gynecol Cancer;
34(5): 697-704, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508587
11.
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
Int J Gynecol Cancer;
2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514101
12.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer;
34(4): 594-601, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296517
13.
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
Cancer;
129(13): 2004-2012, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951509
14.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Cancer Immunol Immunother;
72(1): 183-191, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779095
15.
Cross-sectional survey of surgical practices among gynecologic oncologists in the United States.
Gynecol Oncol;
172: 36-40, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36933401
16.
Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype.
Gynecol Oncol;
171: 15-22, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36804617
17.
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol;
169: 118-124, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36565685
18.
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.
Gynecol Oncol;
178: 27-35, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748268
19.
TERT promoter mutations and gene amplification in endometrial cancer.
Gynecol Oncol;
179: 16-23, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890416
20.
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol;
179: 169-179, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992548